Sutureless aspiration cutter biopsy is beneficial in diagnosing ocular cancers

Article

Sutureless aspiration cutter biopsy can be used to diagnose ocular cancers such as orbital lymphoma.

Sutureless aspiration cutter biopsy can be used to diagnose ocular cancers such as orbital lymphoma, according to a paper featured in the European Journal of Ophthalmology.

Dr Paul T. Finger et al., New York Eye Cancer Center, New York, USA, included three patients in the study with orbital adnexal tumours. Each participant underwent orbital biopsy via a 3 mm incision into the eyelid or conjunctival fornix.

A bimanual technique was used to introduce standard aspiration cutters into the anterior and posterior orbital tumours. The team conducted cytopathology, histopathology and immunohistochemical analysis on all three patients.

The diagnoses were orbital lymphoma, metastatic endometrial adenocarcinoma, and metastatic prostate cancer, with the 20G aspiration cutter yielding the most tissue. The small incisions did not require any sutures.

The technique was strongly linked to fine needle aspiration biopsy, controlled aspiration and enclosed mechanical cutting.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.